SANOFI INDIA
|
The Current P/E Ratio of SANOFI INDIA is 35.60.
Share Price | ₹5,855.2 | May 12,2025 |
Market Cap | ₹13,467.0 Cr | |
Earnings-TTM | ₹378.3 Cr | TTM-Standalone Results |
Price/Earnings | 35.60x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹13,467.0 Cr] as on May 12,2025
(/) Earnings [ ₹378.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 35.60x ]
Thus, for SANOFI INDIA , the investors are currently willing to pay 35.60 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI INDIA
PE Ratio Performance Analysis for SANOFI INDIA
- SANOFI INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2020 averaged 35.35x.
- SANOFI INDIA 's operated at median p/e ratio of 40.06x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SANOFI INDIA 's p/e ratio peaked in Dec2023 at 50.89x.
- SANOFI INDIA 's p/e ratio hit its five-year low in Dec2021 of 19.22x.
How does SANOFI INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SANOFI INDIA | 378.30 | 35.60 | 13,467.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.22 | 404,588.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 76.30 | 157,711.0 |
CIPLA LTD | 5,000.43 | 24.42 | 122,115.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 58.86 | 109,589.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 17.49 | 99,746.6 |
MANKIND PHARMA LTD | 2,050.73 | 50.25 | 103,054.0 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.39 | 89,016.5 |
LUPIN LTD | 2,892.10 | 32.22 | 93,193.1 |
AUROBINDO PHARMA LTD | 3,500.25 | 20.01 | 70,044.7 |
ABBOTT INDIA LTD | 1,334.46 | 47.84 | 63,839.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 17.49x |
Max industry PE | 76.30x |
Median industry PE | 35.22x |
Average industry PE | 37.96x |
You may also like the below Video Courses